-
KaloBios Files For Bankruptcy
Wednesday, December 30, 2015 - 9:56am | 183Shares of KaloBios Pharmaceuticals Inc (NASDAQ: KBIO) have been halted since the company's controversial CEO Martin Shkreli was arrested on fraud charges on December 17. KaloBios has since fired Shkreli and on Monday appealed a decision by the Nasdaq exchange to delist its shares. In the...